NASDAQ: OCEAOcean Biomedical Inc Stock
$1.48-0.03 (-1.99%)
Updated Apr 23, 2024
OCEA Price
$1.48
Fair Value Price
-$0.14
Market Cap
$50.54M
52 Week Low
$0.52
52 Week High
$12.08
P/E
-0.38x
P/B
-0.67x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$98.59M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$9M
Beta
0.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OCEA Overview
Aesther Healthcare Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar combinations with one or more businesses. The company targets the pharmaceutical and medical devices sectors. Aesther was incorporated in 2021 and is based in New York, NY.
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OCEA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OCEA ($1.48) is overvalued by 1,174.44% relative to our estimate of its Fair Value price of -$0.14 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
OCEA ($1.48) is not significantly undervalued (1,174.44%) relative to our estimate of its Fair Value price of -$0.14 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OCEA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OCEA due diligence checks available for Premium users.
Be the first to know about important OCEA news, forecast changes, insider trades & much more!
OCEA News
Valuation
OCEA fair value
Fair Value of OCEA stock based on Discounted Cash Flow (DCF)
Price
$1.48
Fair Value
-$0.14
Undervalued by
1,174.44%
OCEA ($1.48) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OCEA ($1.48) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OCEA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OCEA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.38x
Industry
16.46x
Market
41.92x
OCEA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.67x
Industry
5.93x
OCEA's financial health
Profit margin
Revenue
$0.0
Net Income
-$14.1M
Profit Margin
0%
OCEA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$1.0M
Liabilities
$76.3M
Debt to equity
-1.01
OCEA's short-term liabilities ($30.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OCEA's long-term liabilities ($45.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OCEA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OCEA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.1M
Investing
$0.0
Financing
$0.0
OCEA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OCEA vs Biotech Stocks
Ocean Biomedical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.